In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Lab21 to sell DiagnoCure's Previstage in the UK and Ireland

Executive Summary

Cancer diagnostics company DiagnoCure has granted fellow testing company Lab21 exclusive rights to sell its Previstage GCC colorectal cancer screening tool in the UK and Ireland. Testing samples will be shipped to and processed by DiagnoCure Oncology Laboratories, the US subsidiary of Canada-based DiagnoCure.
Deal Industry
  • Biotechnology
  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
Deal Status
  • Final
Deal Type
  • Alliance
    • Marketing-Licensing

Related Companies